Research foci Infectious Disease Epidemiology

At the Institute of Infectious Disease Epidemiology we develop diagnostic tools and methods to determine and reduce infectious disease burden and sequelae for pathogens causing both acute and chronic illnesses, such as RSV, influenza virus, SARS-CoV-2, measles virus or hepatitis B virus. Larger epidemiological studies performed in collaboration with the institute include NAKO, MuSPAD, RESIST. Differential serological assays to distinguish vaccine- and infection-induced immune responses are deployed in these studies for viral hepatitis, influenza viruses or measles virus, using Luminex® bead-based multiplex technology as a platform technology. 
Epidemiological indicators of protection, infection, reinfection and sequelae from these studies are analyzed using statistical methods and dynamic modelling to gain simulations of future spread and burden of disease (e.g. in RESPINOW). This allows us to analyze spread of infections in the population, predict their dynamics, estimate effect of interventions and assess burden of potential sequelae. 
Digital tools and hubs developed by us include SORMAS and PIA  as well as the Serohub.